Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Dose Comparison Combined with Hydromorphone for Postoperative Analgesia in Lung Cancer
ChiCTR2600123148Phase 4Not yet recruiting
- Sponsor
- Shifang People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and hydromorphone in postoperative pain (4 arms), sponsored by Shifang People's Hospital. Primary endpoints: VAS pain score, Ramsay sedation scale (RSS) and 5 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinehydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600123148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123148.